awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35549863-5841E98F-0784-453C-833D-AFCC132E220C
Q35549863-5841E98F-0784-453C-833D-AFCC132E220C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35549863-5841E98F-0784-453C-833D-AFCC132E220C
An update on the changing indications for androgen deprivation therapy for prostate cancer.
P2860
Q35549863-5841E98F-0784-453C-833D-AFCC132E220C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35549863-5841E98F-0784-453C-833D-AFCC132E220C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
368979dca96301feea197fa0e494a230f6143991
P2860
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.